1.2.2021

EN

Official Journal of the European Union

C 35/55

(Case T-706/20)

(2021/C 35/73)

Language of the case: English

Parties

Applicant: MiMedx Group, Inc. (Marietta, Georgia, United States) (represented by: J. Bogatz and Y. Stone, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: DIZG Deutsches Institut für Zell- und Gewebeersatz gGmbH (Berlin, Germany)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: European Union word mark Epiflex — European Union trade mark No 1 281 385

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 25 September 2020 in Case R 133/2020-2

Form of order sought

The applicant claims that the Court should:

—annul the contested decision

—order EUIPO and the other Party to the proceedings to pay the costs incurred by the applicant.

Pleas in law

—Infringement of Article 58 of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Article 19(1) of Commission Delegated Regulation (EU) 2017/1430;

—Infringement of the principle of equality as laid down in Article 20 in conjunction with Article 41 of the Charter of Fundamental Rights of the European Union (‘the Charter’);

—Infringement of right to good administration as laid down in Article 41(1) of the Charter;

—Infringement of right to a fair trial as laid down in Article 47 of the Charter;

—Infringement of Article 95(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Articles 19(1), third sentence, and 10(7) of Commission Delegated Regulation (EU) 2017/1430.